JP2016540021A5 - - Google Patents

Download PDF

Info

Publication number
JP2016540021A5
JP2016540021A5 JP2016539161A JP2016539161A JP2016540021A5 JP 2016540021 A5 JP2016540021 A5 JP 2016540021A5 JP 2016539161 A JP2016539161 A JP 2016539161A JP 2016539161 A JP2016539161 A JP 2016539161A JP 2016540021 A5 JP2016540021 A5 JP 2016540021A5
Authority
JP
Japan
Prior art keywords
dosage form
unit dosage
solid unit
solid
form according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016539161A
Other languages
English (en)
Japanese (ja)
Other versions
JP6447931B2 (ja
JP2016540021A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/077127 external-priority patent/WO2015086643A1/en
Publication of JP2016540021A publication Critical patent/JP2016540021A/ja
Publication of JP2016540021A5 publication Critical patent/JP2016540021A5/ja
Application granted granted Critical
Publication of JP6447931B2 publication Critical patent/JP6447931B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016539161A 2013-12-12 2014-12-10 エステトロール成分を含有する口腔内崩壊固体単位剤形 Expired - Fee Related JP6447931B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13196904 2013-12-12
EP13196904.0 2013-12-12
PCT/EP2014/077127 WO2015086643A1 (en) 2013-12-12 2014-12-10 Orally disintegrating solid dosage unit containing an estetrol component

Publications (3)

Publication Number Publication Date
JP2016540021A JP2016540021A (ja) 2016-12-22
JP2016540021A5 true JP2016540021A5 (enExample) 2018-01-25
JP6447931B2 JP6447931B2 (ja) 2019-01-09

Family

ID=49759137

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016539161A Expired - Fee Related JP6447931B2 (ja) 2013-12-12 2014-12-10 エステトロール成分を含有する口腔内崩壊固体単位剤形

Country Status (30)

Country Link
US (2) US9884064B2 (enExample)
EP (1) EP3079671B1 (enExample)
JP (1) JP6447931B2 (enExample)
KR (1) KR102265150B1 (enExample)
CN (1) CN105979935B (enExample)
AU (1) AU2014363599B2 (enExample)
BR (1) BR112016013502B1 (enExample)
CA (1) CA2932855C (enExample)
CL (1) CL2016001411A1 (enExample)
CY (1) CY1119817T1 (enExample)
DK (1) DK3079671T3 (enExample)
EA (1) EA032306B1 (enExample)
ES (1) ES2655076T3 (enExample)
HR (1) HRP20180129T1 (enExample)
HU (1) HUE035848T2 (enExample)
IL (1) IL246082B (enExample)
LT (1) LT3079671T (enExample)
MA (1) MA39105B1 (enExample)
MX (1) MX369035B (enExample)
NO (1) NO3079671T3 (enExample)
NZ (1) NZ720906A (enExample)
PL (1) PL3079671T3 (enExample)
PT (1) PT3079671T (enExample)
RS (1) RS56738B1 (enExample)
SG (1) SG11201604741UA (enExample)
SI (1) SI3079671T1 (enExample)
SM (1) SMT201700582T1 (enExample)
TN (1) TN2016000230A1 (enExample)
WO (1) WO2015086643A1 (enExample)
ZA (1) ZA201603903B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS54880B1 (sr) 2011-06-01 2016-10-31 Estetra Sprl Postupak proizvodnje intermedijarnih proizvoda estetrola
ME02585B (me) 2011-06-01 2017-06-20 Estetra Sprl Postupak proizvodnje intermedijara estetrola
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
CA2843951C (en) * 2011-08-11 2019-08-06 Wout WOUTERS Use of estetrol as emergency contraceptive
LT3310345T (lt) * 2015-06-18 2021-06-25 Estetra Sprl Burnoje disperguojama tabletė, turinti estetrolio
CU24523B1 (es) * 2015-06-18 2021-06-08 Estetra Sprl Unidad de dosificación orodispersable que contiene un componente estetrol
MA44206B1 (fr) 2015-06-18 2021-04-30 Estetra Sprl Comprimé orodispersible comprenant estetrol
EP3701944B1 (en) 2015-06-18 2021-12-08 Estetra SRL Orodispersible dosage unit containing an estetrol component
CA3178291A1 (en) * 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
US20200046729A1 (en) * 2016-08-05 2020-02-13 Estetra Sprl Methods using combined oral contraceptive compositions with reduced cardiovascular effects
IL276584B2 (en) * 2018-02-07 2024-10-01 Estetra Srl Contraceptive composition with reduced cardiovascular effects
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
EP3781171B1 (en) * 2018-04-19 2022-02-09 Estetra SRL Compounds and their uses for alleviating menopause-associated symptoms
HU231240B1 (hu) 2019-09-03 2022-04-28 Richter Gedeon Nyrt. Ipari eljárás nagytisztaságú ösztetrol hatóanyag előállítására
DE112020004564T5 (de) * 2019-09-27 2022-06-15 Industriale Chimica S.R.L. VERFAHREN ZUM HERSTELLEN VON (15α,16α,17β)-ESTRA-1,3,5(10)-TRIEN-3,15,16,17-TETROL (ESTETROL) UND ZWISCHENSTUFEN DES VERFAHRENS
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
CN113552768B (zh) 2020-04-24 2025-06-17 爱天思株式会社 感光性着色组合物、彩色滤光片及图像显示装置
AU2021351921A1 (en) 2020-09-29 2023-04-06 Millicent Pharma Limited Orodispersible formulations
JP2026503158A (ja) 2023-02-02 2026-01-27 インダストリアーレ キミカ エッセ．エッレ．エッレ． （１５α，１６α，１７β）－エストラ－１，３，５（１０）－トリエン－３，１５，１６，１７－テトロール（エステトロール）一水和物の調製方法
HUP2400151A1 (hu) 2024-02-28 2025-09-28 Richter Gedeon Nyrt Ösztetrol-monohidrát kristályosítási eljárás
WO2025181200A1 (en) 2024-02-28 2025-09-04 Estetra Srl Estetrol polymorphic form and production thereof

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997004752A1 (en) * 1995-07-26 1997-02-13 Duramed Pharmaceuticals, Inc. Pharmaceutical compositions of conjugated estrogens and methods for their use
US6117446A (en) 1999-01-26 2000-09-12 Place; Virgil A. Drug dosage unit for buccal administration of steroidal active agents
DE60217324T2 (de) * 2001-05-18 2007-04-26 Pantarhei Bioscience B.V. Pharmazeutische zusammensetzung für die hormonersatztherapie
EP1260225A1 (en) 2001-05-18 2002-11-27 Pantarhei Bioscience B.V. A pharmaceutical composition for use in hormone replacement therapy
DE60234515D1 (de) 2001-05-23 2010-01-07 Pantarhei Bioscience Bv Tetrahydroxylierte estrogen enthaltendes arzneistoffverabreichungssystem zur verwendung in hormonalen kontrazeption
DK1390042T3 (da) * 2001-05-23 2008-03-31 Pantarhei Bioscience Bv System for administration af et lægemiddel omfattende tetrahydroxyleret östrogen til anvendelse i hormonal svangerskabsforebyggelse
WO2003018026A1 (en) 2001-08-31 2003-03-06 Pantarhei Bioscience B.V. Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
DE60216630T2 (de) 2001-11-15 2007-09-20 Pantarhei Bioscience B.V. Verwendung von östrogen in kombination mit progestogen für die hormonsubstitutiionstherapie
JP5037779B2 (ja) * 2002-02-21 2012-10-03 バイエル ファーマ アクチエンゲゼルシャフト １又は複数のステロイド、１又は複数のテトラヒドロ葉酸成分およびビタミンｂ１２を含む医薬組成物
GB0410616D0 (en) 2004-05-13 2004-06-16 Unilever Plc Antiperspirant or deodorant compositions
US20070048369A1 (en) 2005-08-26 2007-03-01 National Starch And Chemical Investment Holding Corporation Mucosal delivery tablet
US20090221540A1 (en) 2006-01-09 2009-09-03 Pantarhei Bioscience B.V. Method of Treating An Acute Vascular Disorder
MX2008014941A (es) * 2006-06-08 2008-12-10 Warner Chilcott Co Inc Metodos para administrar formas de dosificacion solida de etinil estradiol y profarmacos del mismo con biodisponibilidad mejorada.
US20070286819A1 (en) * 2006-06-08 2007-12-13 Warner Chilcott Company, Inc. Methods to administer ethinyl estradiol and prodrugs thereof with improved bioavailability
JP2010511062A (ja) * 2006-11-29 2010-04-08 ワイス エルエルシー エストロゲン／ｓｅｒｍおよびエストロゲン／プロゲスチン二層錠剤
RU2465907C2 (ru) * 2006-12-20 2012-11-10 Тева Вимен'С Хелс, Инк. Распадающиеся в полости рта твердые дозированные формы, содержащие прогестин, и способы получения и применение указанных дозированных форм
EP2117518A2 (en) * 2007-01-12 2009-11-18 Wyeth a Corporation of the State of Delaware Tablet-in-tablet compositions
EP2155205B1 (en) * 2007-06-21 2011-12-21 Pantarhei Bioscience B.V. Treatment of meconium aspiration syndrome with estrogens
US20110250274A1 (en) 2008-09-19 2011-10-13 Shaked Ze Ev Estriol formulations
DE102009007771B4 (de) * 2009-02-05 2012-02-16 Bayer Schering Pharma Aktiengesellschaft Bukkales Applikationssystem, 17α-Estradiol enthaltend
CN102058604A (zh) * 2009-11-17 2011-05-18 北京万全阳光医学技术有限公司 一种含有地诺孕素和戊酸雌二醇的药物组合物及其制备方法
WO2014159377A1 (en) 2013-03-14 2014-10-02 Teva Women's Health, Inc. Compositions containing tanaproget and natural estrogens

Similar Documents

Publication Publication Date Title
AU2014363599B2 (en) Orally disintegrating solid dosage unit containing an estetrol component
HRP20210555T1 (hr) Orodisperzibilna tableta koja sadrži estetrol
JP2015166379A5 (enExample)
JP6446552B2 (ja) 体重と体脂肪減少に用いられる組成物およびその医薬品と使用
TW200803857A (en) Use of flibanserin for the treatment of pre-menopausal sexual desire disorders
JP2008520736A5 (enExample)
JP2010522137A5 (enExample)
JP2013529665A5 (enExample)
ES2606307T3 (es) Producto de co-micronización que comprende acetato de ulipristal
FI3710000T3 (fi) Tradipitantti käytettäväksi gastropareesin hoidossa
RU2017133990A (ru) Фармацевтические лекарственные формы ингибитора тирозинкиназы брутона
JP2014221827A5 (enExample)
HRP20131088T1 (hr) Äśvrsti farmaceutski pripravci s fiksnom dozom koji sadrže irbesartan i amlodipin, njihova priprava i terapijska primjena
RU2016117186A (ru) Комбинированная композиция, содержащая тадалафил и амлодипин
JP2022552187A5 (enExample)
CN105338970B (zh) 包含他达拉非和坦洛新的药物胶囊复合制剂
CN104606232A (zh) 一种氨咖黄敏胶囊及其制备方法
RU2016137926A (ru) Композиции грапипранта и способы их применения
RU2015132902A (ru) Новый быстрорастворимый состав гранул с улучшенной растворимостью
JP2015120758A5 (enExample)
CN104706604A (zh) 一种吡仑帕奈冻干口崩片及其制备方法
JP2016505050A5 (enExample)
RU2020120156A (ru) Лечение приливов и потери костной ткани, вызванных андрогенной депривационной терапией с применением цис-кломифена
WO2014040524A1 (zh) 3-正丁基异吲哚啉酮在制备预防和治疗脑梗塞的药物中的应用
RU2018126670A (ru) Фармацевтическая композиция для лечения гиперплазии предстательной железы